Mackenzie Financial
GSK icon

Mackenzie Financial’s GSK GSK Stock Holding History

Mackenzie Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Sell
62,190
-81,381
-57% -$4.3M ﹤0.01% 936
2026
Q1 		$7.92M Sell
143,571
-28,031
-16% -$1.52M 0.01% 570
2025
Q4 		$8.44M Sell
171,602
-26,753
-13% -$1.25M 0.01% 535
2025
Q3 		$8.56M Buy
198,355
+8,947
+5% +$349K 0.01% 528
2025
Q2 		$7.27M Buy
189,408
+35,203
+23% +$1.35M 0.01% 534
2025
Q1 		$5.97M Buy
+154,205
New +$5.65M 0.01% 543
2018
Q4 		– Sell
-22,037
Closed -$1.11M – 1177
2018
Q3 		$1.11M Sell
22,037
-104
-0.5% -$5.28K ﹤0.01% 742
2018
Q2 		$1.12M Buy
22,141
+8,895
+67% +$448K ﹤0.01% 669
2018
Q1 		$647K Buy
13,246
+2,092
+19% +$97.4K ﹤0.01% 694
2017
Q4 		$495K Buy
11,154
+3,165
+40% +$146K ﹤0.01% 689
2017
Q3 		$405K Buy
7,989
+460
+6% +$23.3K ﹤0.01% 537
2017
Q2 		$406K Buy
7,529
+3,689
+96% +$197K ﹤0.01% 535
2017
Q1 		$202K Buy
+3,840
New +$195K ﹤0.01% 606

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial's GSK Position: Q2 2026 in Review

Mackenzie Financial reduced its GSK (GSK) stake by 57% in Q2 2026, selling an estimated $4.3M and leaving 62,190 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Mackenzie Financial first reported a position in GSK in Q1 2017 and has held it in 13 quarters since. The position peaked at $8.56M in Q3 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Mackenzie Financial held 62,190 shares of GSK worth $3.26M as of Q2 2026.
  • Mackenzie Financial sold 81,381 GSK shares in Q2 2026, an estimated $4.3M.
  • GSK made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #936 holding.
  • Mackenzie Financial first reported a position in GSK in Q1 2017 and has held it in 13 quarters since.
  • Mackenzie Financial's GSK position peaked at $8.56M in Q3 2025.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.